{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:58:26Z","timestamp":1790888306288,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012001","name":"Al Jalila Foundation","doi-asserted-by":"publisher","award":["AJF202058"],"award-info":[{"award-number":["AJF202058"]}],"id":[{"id":"10.13039\/100012001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016714","name":"University of Sharjah","doi-asserted-by":"publisher","award":["CoV19-0306"],"award-info":[{"award-number":["CoV19-0306"]}],"id":[{"id":"10.13039\/100016714","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006928","name":"Ohio State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002724","name":"American University of Sharjah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002724","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010842","name":"Temple University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010842","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ejmech.2023.115380","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T02:45:32Z","timestamp":1681699532000},"page":"115380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Discovery of novel papain-like protease inhibitors for potential treatment of COVID-19"],"prefix":"10.1016","volume":"254","author":[{"given":"Fatema","family":"Hersi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusha","family":"Sebastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamadeh","family":"Tarazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vunnam","family":"Srinivasulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdou Kamal","family":"Allayeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Y.","family":"Hachim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imad A.","family":"Abu-Yousef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin F.","family":"Majdalawieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana M.","family":"Zaher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany A.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4914-9677","authenticated-orcid":false,"given":"Taleb H.","family":"Al-Tel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115380_bib1","first-page":"110","article-title":"SARS-CoV-2 and the pandemic of COVID-19, Postgrad","volume":"97","author":"Adil","year":"2021","journal-title":"Med. J."},{"key":"10.1016\/j.ejmech.2023.115380_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V'Kovski","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2023.115380_bib3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12931-020-01479-w","article-title":"From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses","volume":"21","author":"Zhu","year":"2020","journal-title":"Respir. Res."},{"key":"10.1016\/j.ejmech.2023.115380_bib4","doi-asserted-by":"crossref","first-page":"7561","DOI":"10.1021\/acs.jmedchem.2c00303","article-title":"Progress and challenges in targeting the SARS-CoV-2 papain-like protease","volume":"65","author":"Tan","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115380_bib5","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1021\/acs.jmedchem.0c01140","article-title":"Targeting SARS-CoV-2 proteases and polymerase for COVID-19 treatment: state of the art and future opportunities","volume":"65","author":"Cannalire","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115380_bib6","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of covid-19 - final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2023.115380_bib7","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.15190\/d.2022.10","article-title":"Remdesivir: the first FDA-approved anti-COVID-19 treatment for young children","volume":"10","author":"Chera","year":"2022","journal-title":"Discoveries"},{"key":"10.1016\/j.ejmech.2023.115380_bib8","first-page":"o1695","article-title":"Covid-19: FDA authorizes pharmacists to prescribe Paxlovid, B.M","volume":"378","author":"Tanne","year":"2022","journal-title":"J"},{"key":"10.1016\/j.ejmech.2023.115380_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27030658","article-title":"Approaches to the potential therapy of COVID-19: a general overview from the medicinal chemistry perspective","volume":"27","author":"Menendez","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115380_bib10","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41594-021-00651-0","article-title":"Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis","volume":"28","author":"Kabinger","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2023.115380_bib11","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.tips.2022.08.008","article-title":"Targeting SARS-CoV-2 papain-like protease in the postvaccine era","volume":"43","author":"Ton","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2023.115380_bib12","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41467-020-20718-8","article-title":"The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery","volume":"12","author":"Fu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2023.115380_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.822785","article-title":"Potential inhibitors targeting papain-like protease of SARS-CoV-2: two birds with one stone","volume":"10","author":"Jiang","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2023.115380_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.876212","article-title":"Inhibitors of SARS-CoV-2 PLpro","volume":"10","author":"Calleja","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2023.115380_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.tips.2022.08.008","article-title":"Targeting SARS-CoV-2 papain-like protease in the postvaccine era","author":"Ton","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2023.115380_bib16","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1021\/acsptsci.0c00093","article-title":"Can papain-like protease inhibitors halt SARS-CoV-2 replication?","volume":"3","author":"Maiti","year":"2020","journal-title":"A.C.S. Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ejmech.2023.115380_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd4596","article-title":"Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: a framework for anti-COVID-19 drug design","volume":"6","author":"Rut","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2023.115380_bib18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-020-2601-5","article-title":"Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity","volume":"587","author":"Shin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.115380_bib19","doi-asserted-by":"crossref","first-page":"8783","DOI":"10.1074\/jbc.C800030200","article-title":"ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response","volume":"283","author":"Malakhova","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115380_bib20","doi-asserted-by":"crossref","first-page":"14476","DOI":"10.1021\/acs.joc.9b01919","article-title":"Sequencing [4 + 1]-cycloaddition and aza-michael addition reactions: a diastereoselective cascade for the rapid access of pyrido[2',1':2,3]\/thiazolo[2',3':2,3]imidazo[1,5-a]quinolone scaffolds as potential antibacterial and anticancer motifs","volume":"84","author":"Srinivasulu","year":"2019","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2023.115380_bib21","doi-asserted-by":"crossref","first-page":"10695","DOI":"10.1021\/acs.joc.0c01244","article-title":"Divergent strategy for diastereocontrolled synthesis of small- and medium-ring architectures","volume":"85","author":"Srinivasulu","year":"2020","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2023.115380_bib22","doi-asserted-by":"crossref","first-page":"12872","DOI":"10.1021\/acs.joc.1c01523","article-title":"Stereoselective late-stage transformations of indolo[2,3-a]quinolizines skeleta to nature-inspired scaffolds","volume":"86","author":"Srinivasulu","year":"2021","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2023.115380_bib23","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1021\/acs.joc.1c02698","article-title":"Stereodivergent Complexity-to-Diversity Strategy en Route to the Synthesis of Nature-Inspired Skeleta","volume":"87","author":"Srinivasulu","year":"2022","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2023.115380_bib24","doi-asserted-by":"crossref","first-page":"14182","DOI":"10.1002\/chem.201702495","article-title":"Modular Bi-directional one-pot strategies for the diastereoselective synthesis of structurally diverse collections of constrained beta-carboline-benzoxazepines","volume":"23","author":"Srinivasulu","year":"2017","journal-title":"Chemistry"},{"key":"10.1016\/j.ejmech.2023.115380_bib25","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1038\/s41467-018-07521-2","article-title":"Multidirectional desymmetrization of pluripotent building block en route to diastereoselective synthesis of complex nature-inspired scaffolds","volume":"9","author":"Srinivasulu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2023.115380_bib26","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1021\/acs.joc.8b02878","article-title":"One-pot synthesis of diverse collections of benzoxazepine and indolopyrazine fused to heterocyclic systems","volume":"84","author":"Srinivasulu","year":"2019","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2023.115380_bib27","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1021\/acs.orglett.7b03986","article-title":"Post-ugi cascade transformations for accessing diverse chromenopyrrole collections","volume":"20","author":"Srinivasulu","year":"2018","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2023.115380_bib28","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41467-021-21060-3","article-title":"Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors","volume":"12","author":"Osipiuk","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2023.115380_bib29","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.drudis.2006.03.004","article-title":"Biological assay challenges from compound solubility: strategies for bioassay optimization","volume":"11","author":"Di","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2023.115380_bib30","first-page":"321","article-title":"Evaluation of compound optical interference in high-content screening","volume":"23","author":"Ibanez","year":"2018","journal-title":"S.L.A.S. Discov."},{"key":"10.1016\/j.ejmech.2023.115380_bib31","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1021\/acsptsci.1c00240","article-title":"Validation and invalidation of SARS-CoV-2 papain-like protease inhibitors","volume":"5","author":"Ma","year":"2022","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.ejmech.2023.115380_bib32","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1021\/acsinfecdis.0c00168","article-title":"Characterization and noncovalent inhibition of the deubiquitinase and deISGylase activity of SARS-CoV-2 papain-like protease","volume":"6","author":"Freitas","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2023.115380_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ph13120443","article-title":"FDA-approved drugs with potent in vitro antiviral activity against severe acute respiratory syndrome coronavirus 2","volume":"13","author":"Mostafa","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2023.115380_bib34","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/s41590-021-01035-8","article-title":"Altered ISGylation drives aberrant macrophage-dependent immune responses during SARS-CoV-2 infection","volume":"22","author":"Munnur","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejmech.2023.115380_bib35","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1021\/jm034111v","volume":"46","author":"Wu","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115380_bib36","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2174\/138920008786485119","article-title":"Permeability for intestinal absorption: Caco-2 assay and related issues","volume":"9","author":"Press","year":"2008","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.ejmech.2023.115380_bib37","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fmolb.2020.00174","article-title":"Insights into dynamics of inhibitor and ubiquitin-like protein binding in SARS-CoV-2 papain-like protease","volume":"7","author":"Bosken","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ejmech.2023.115380_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.592289","article-title":"Supporting SARS-CoV-2 papain-like protease drug discovery: in silico methods and benchmarking","volume":"8","author":"Ibrahim","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2023.115380_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104295","article-title":"Targeting multiple conformations of SARS-CoV2 Papain-Like Protease for drug repositioning: an in-silico study","volume":"131","author":"Ismail","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.ejmech.2023.115380_bib40","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","article-title":"SARS-CoV-2 vaccines in development","volume":"586","author":"Krammer","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.115380_bib41","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.immuni.2021.07.017","article-title":"Accelerated COVID-19 vaccine development: milestones, lessons, and prospects","volume":"54","author":"Bok","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2023.115380_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100882","article-title":"The Omicron variant of concern: diversification and convergent evolution in spike protein, and escape from anti-Spike monoclonal antibodies","volume":"65","author":"Focosi","year":"2022","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejmech.2023.115380_bib43","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41586-022-04479-6","article-title":"SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo","volume":"603","author":"Hui","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.115380_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104158","article-title":"Limited neutralization of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies","volume":"82","author":"Wilhelm","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejmech.2023.115380_bib45","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.chom.2022.04.014","article-title":"Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2","volume":"30","author":"Evans","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejmech.2023.115380_bib46","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.chom.2022.09.015","article-title":"Evasion of neutralizing antibody responses by the SARS-CoV-2 BA.2.75 variant","volume":"30","author":"Qu","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejmech.2023.115380_bib47","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMc2210546","article-title":"Durability of booster mRNA vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 subvariants","volume":"387","author":"Qu","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2023.115380_bib48","series-title":"Enhanced Neutralization Resistance of SARS-CoV-2 Omicron Subvariants BQ.1","author":"Qu","year":"2022"},{"key":"10.1016\/j.ejmech.2023.115380_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105429","article-title":"Generation of a VeroE6 Pgp gene knock out cell line and its use in SARS-CoV-2 antiviral study","volume":"208","author":"Zhu","year":"2022","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2023.115380_bib50","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00428-021-03262-8","article-title":"Variable levels of spike and ORF1ab RNA in post-mortem lung samples of SARS-CoV-2-positive subjects: comparison between ISH and RT-PCR","volume":"480","author":"Zito Marino","year":"2022","journal-title":"Virchows Arch."},{"key":"10.1016\/j.ejmech.2023.115380_bib51","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1038\/s41598-022-06104-y","article-title":"Aloin isoforms (A and B) selectively inhibits proteolytic and deubiquitinating activity of papain like protease (PLpro) of SARS-CoV-2 in vitro","volume":"12","author":"Lewis","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2023.115380_bib52","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cytogfr.2020.06.001","article-title":"SARS-CoV-2 infection: the role of cytokines in COVID-19 disease","volume":"54","author":"Costela-Ruiz","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ejmech.2023.115380_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008737","article-title":"Interplay between SARS-CoV-2 and the type I interferon response","volume":"16","author":"Sa Ribero","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2023.115380_bib54","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1007\/s00705-021-05247-z","article-title":"Pro-inflammatory CXCL-10, TNF-alpha, IL-1beta, and IL-6: biomarkers of SARS-CoV-2 infection","volume":"166","author":"Tripathy","year":"2021","journal-title":"Arch. Virol."},{"key":"10.1016\/j.ejmech.2023.115380_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02489-4","article-title":"Upregulated type I interferon responses in asymptomatic COVID-19 infection are associated with improved clinical outcome","volume":"11","author":"Masood","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2023.115380_bib56","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/eji.201040391","article-title":"IL-6: regulator of Treg\/Th17 balance","volume":"40","author":"Kimura","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejmech.2023.115380_bib57","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cytogfr.2015.07.004","article-title":"Interleukin-6: biology, signaling and strategies of blockade","volume":"26","author":"Schaper","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ejmech.2023.115380_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104153","article-title":"Robust long-term immunity to SARS-CoV-2 in patients recovered from severe COVID-19 after interleukin-6 blockade","volume":"82","author":"Masia","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejmech.2023.115380_bib59","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/jama.2021.11121","article-title":"IL-6 receptor antagonist therapy for patients hospitalized for COVID-19: who, when, and how?","volume":"326","author":"Matthay","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ejmech.2023.115380_bib60","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot087379","article-title":"Crystal violet assay for determining viability of cultured cells","author":"Feoktistova","year":"2016","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.ejmech.2023.115380_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-17082-6","article-title":"Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies","volume":"12","author":"Kutkat","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2023.115380_bib62","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1021\/acs.jcim.1c00684","article-title":"Discovery of novel small-molecule inhibitors of SARS-CoV-2 main protease as potential leads for COVID-19 treatment","volume":"61","author":"Manandhar","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2023.115380_bib63","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejps.2014.02.008","article-title":"Applications of a 7-day Caco-2 cell model in drug discovery and development","volume":"56","author":"Peng","year":"2014","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2023.115380_bib64","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.taap.2017.03.021","article-title":"Caffeic acid phenethyl ester protects against glucocorticoid-induced osteoporosis in vivo: impact on oxidative stress and RANKL\/OPG signals","volume":"324","author":"Tolba","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115380_bib65","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/B:JCAM.0000035186.90683.f2","article-title":"VEGA--an open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming","volume":"18","author":"Pedretti","year":"2004","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2023.115380_bib66","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1515\/acph-2015-0015","article-title":"Immunomodulatory effects of inosine pranobex on cytokine production by human lymphocytes","volume":"65","author":"Lasek","year":"2015","journal-title":"Acta Pharm."},{"key":"10.1016\/j.ejmech.2023.115380_bib67","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2023.115380_bib68","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2023.115380_bib69","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3389\/fmicb.2018.00526","article-title":"NS segment of a 1918 influenza A virus-descendent enhances replication of H1N1pdm09 and virus-induced cellular immune response in mammalian and avian systems","volume":"9","author":"Petersen","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2023.115380_bib70","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13075-022-02880-0","article-title":"Regulation of type I interferon signature by VGLL3 in the fibroblast-like synoviocytes of rheumatoid arthritis patients via targeting the Hippo pathway","volume":"24","author":"Du","year":"2022","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejmech.2023.115380_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015142","article-title":"Cellular reactive oxygen species inhibit MPYS induction of IFNbeta","volume":"5","author":"Jin","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2023.115380_bib72","doi-asserted-by":"crossref","first-page":"865","DOI":"10.4049\/jimmunol.1402389","article-title":"Age-associated failure to adjust type I IFN receptor signaling thresholds after T cell activation","volume":"195","author":"Li","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejmech.2023.115380_bib73","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1743-422X-7-219","article-title":"Host gene expression profiling in influenza A virus-infected lung epithelial (A549) cells: a comparative analysis between highly pathogenic and modified H5N1 viruses","volume":"7","author":"Chakrabarti","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.ejmech.2023.115380_bib74","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1084\/jem.20130012","article-title":"IL28B expression depends on a novel TT\/-G polymorphism which improves HCV clearance prediction","volume":"210","author":"Bibert","year":"2013","journal-title":"J. Exp. Med."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342300346X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342300346X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:51:46Z","timestamp":1759330306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342300346X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":74,"alternative-id":["S022352342300346X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115380","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel papain-like protease inhibitors for potential treatment of COVID-19","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115380"}}